{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:08:33Z","timestamp":1788926913698,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.berh.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T16:19:31Z","timestamp":1349453971000},"page":"459-475","source":"Crossref","is-referenced-by-count":59,"title":["Osteo-articular manifestations of amyloidosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Pauline","family":"M'Bapp\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2012.07.003_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13506129.2010.526812","article-title":"Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis","volume":"17","author":"Sipe","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.berh.2012.07.003_bib2","article-title":"Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis","volume":"April 11","author":"Sethi","year":"2012","journal-title":"Kidney International"},{"key":"10.1016\/j.berh.2012.07.003_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/13506129709003838","article-title":"Amyloid P component. A critical review","volume":"4","author":"Pepys","year":"1997","journal-title":"Amyloid"},{"key":"10.1016\/j.berh.2012.07.003_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: history of the amyloid fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"Journal of Structural Biology"},{"key":"10.1016\/j.berh.2012.07.003_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1525-139X.2009.00584.x","article-title":"Beta2-microglobulin","volume":"22","author":"Dr\u00fceke","year":"2009","journal-title":"Seminars in Dialysis"},{"key":"10.1016\/j.berh.2012.07.003_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.revmed.2007.01.004","article-title":"Les amyloses \u00e0 transthyr\u00e9tine","volume":"28","author":"Magy-Bertrand","year":"2007","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"10.1016\/j.berh.2012.07.003_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1051\/medsci\/2005216-7627","article-title":"Les amyloses, un mod\u00e8le de maladie du repliement des prot\u00e9\u00efnes","volume":"21","author":"Grateau","year":"2005","journal-title":"M\u00e9decine Sciences (Paris)"},{"key":"10.1016\/j.berh.2012.07.003_bib9","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.berh.2012.07.003_bib10","series-title":"Reactive amyloidosis and the acute phase response. Bailli\u00e8re's clinical rheumatology","first-page":"627","article-title":"The epidemiology of AL and AA amyloidosis","author":"Simms","year":"1994"},{"key":"10.1016\/j.berh.2012.07.003_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood-2011-06-358895","article-title":"Immunoglobulin D amyloidosis: a distinct entity","volume":"119","author":"Gertz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.berh.2012.07.003_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ajh.21934","article-title":"Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"Gertz","year":"2011","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.berh.2012.07.003_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MD.0b13e31816c43b6","article-title":"The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients","volume":"87","author":"Terrier","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2012.07.003_bib14","first-page":"665","article-title":"Amyloidosis (AL). Clinical and laboratoty features in 229 cases","volume":"58","author":"Kyle","year":"1983","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.berh.2012.07.003_bib15","first-page":"25","article-title":"Articular complications of Kahler's disease. Results of a survey of 1953 cases of plasmocytic myelomas","volume":"42","author":"Villaumey","year":"1975","journal-title":"Revue du Rhumatisme et des Maladies Osteo-articulaires"},{"key":"10.1016\/j.berh.2012.07.003_bib16","first-page":"1473","article-title":"Amyloid arthropathy in the course of multiple myeloma","volume":"29","author":"Fautrel","year":"2002","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.07.003_bib17","first-page":"689","article-title":"Amylose synoviale r\u00e9v\u00e9latrice de my\u00e9lome. Aspects cliniques, arthroscopiques et immunochimiques","volume":"55","author":"Krause","year":"1988","journal-title":"Revue du Rhumatisme et des Maladies Osteo-articulaires"},{"key":"10.1016\/j.berh.2012.07.003_bib18","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0025-6196(12)65706-1","article-title":"Primary systemic amyloidosis \u2013 a diagnostic primer","volume":"64","author":"Gertz","year":"1989","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.berh.2012.07.003_bib19","first-page":"287","article-title":"Les atteintes articulaires de l'amylose AL","volume":"150","author":"Blanco","year":"1999","journal-title":"Annales de m\u00e9decine interne"},{"key":"10.1016\/j.berh.2012.07.003_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.revmed.2004.02.007","article-title":"Light chain multiple myeloma revealed by an amyloid arthropathy. A report of two cases","volume":"25","author":"Hamza","year":"2004","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"10.1016\/j.berh.2012.07.003_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0248-8663(94)80026-X","article-title":"Cartographie de l'amylose par scintigraphie au composant s\u00e9rique amylo\u00efde P marqu\u00e9 \u00e0 l'iode 123: mythe ou r\u00e9alit\u00e9?","volume":"15","author":"Hachulla","year":"1994","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"10.1016\/j.berh.2012.07.003_bib23","first-page":"189","article-title":"Temporal artery involvement revealing AL amyloidosis and Ig D monoclonal gammapathy","volume":"23","author":"Rodon","year":"1996","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.07.003_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/ard.52.2.158","article-title":"Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmatic malignancy in a man presenting as polymyalgia rheumatica","volume":"52","author":"Lafforgue","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2012.07.003_bib25","series-title":"Diagnosis of bone and joint disorders","first-page":"2387","article-title":"Amyloidosis","author":"Resnick","year":"1988"},{"key":"10.1016\/j.berh.2012.07.003_bib26","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1002\/art.22959","article-title":"Soft tissue, joint, and bone manifestations of AL amyloidosis","volume":"56","author":"Prokaeva","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.07.003_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM197302152880709","article-title":"The shoulder \u2013 pad sign- a diagnostic feature of amyloid arthropathy","volume":"288","author":"Katz","year":"1973","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib28","first-page":"269","article-title":"Polyarthrite rhumato\u00efde et my\u00e9lome multiple: a propos de vingt-deux observations, R\u00e9sultats d'une enqu\u00eate nationale multicentrique","volume":"60","author":"Flipo","year":"1993","journal-title":"Revue du Rhumatisme"},{"key":"10.1016\/j.berh.2012.07.003_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9343(73)90162-9","article-title":"Amyloid arthritis simulating rheumatoid disease in five patients with multiple myeloma","volume":"55","author":"Gordon","year":"1973","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.1780300409","article-title":"Synovial fluid analysis for diagnosis of amyloid arthropathy","volume":"30","author":"Lakhanpal","year":"1987","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.07.003_bib31","first-page":"1025","article-title":"Amylose osseuse primitive: aspects en IRM","volume":"76","author":"Faure","year":"1995","journal-title":"Radiologie"},{"key":"10.1016\/j.berh.2012.07.003_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1259\/bjr.73.873.11064661","article-title":"Extensive soft tissue uptake of 99Tcm methylene diphosphonate in a patient with multiple myeloma","volume":"73","author":"Evans","year":"2000","journal-title":"British Journal of Radiology"},{"key":"10.1016\/j.berh.2012.07.003_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/RLU.0b013e3181feefd4","article-title":"Visualisation of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET\/CT Scan","volume":"36","author":"Mekinian","year":"2011","journal-title":"Clinical Nuclear Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib34","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/art.1780401028","article-title":"Amyloid arthropathy","volume":"40","author":"Penrod","year":"1997","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.07.003_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/asheducation-2010.1.287","article-title":"Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy","volume":"2010","author":"Cohen","year":"2010","journal-title":"Hematology American Society of Hematology Education Program"},{"key":"10.1016\/j.berh.2012.07.003_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/CCO.0b013e328342b840","article-title":"Transplantation vs. conventional-dose therapy for amyloidosis","volume":"23","author":"Palladini","year":"2011","journal-title":"Current Opinion in Oncology"},{"key":"10.1016\/j.berh.2012.07.003_bib37","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2005-07-2922","article-title":"Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem transplantation","volume":"107","author":"Dispenzieri","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.berh.2012.07.003_bib38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2008.004119","article-title":"Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain","volume":"94","author":"Van Gameren","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.berh.2012.07.003_bib39","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proceedings of Natural Academy of Sciences USA"},{"key":"10.1016\/j.berh.2012.07.003_bib40","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2010-05-286567","article-title":"The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis","volume":"116","author":"Palladini","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.berh.2012.07.003_bib41","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2012.07.003_bib42","first-page":"48","article-title":"Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion [12th international symposium on amyloidosis abstracts]","volume":"17","author":"Gertz","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.berh.2012.07.003_bib43","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","article-title":"Amyloidosis: pathogenesis and new therapeutic options","volume":"29","author":"Merlini","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.berh.2012.07.003_bib44","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amiloidosis: colchicine alone, melphalan and prednisone, prednisone and colchicine","volume":"336","author":"Ra","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib46","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1182\/blood-2011-01-330738","article-title":"Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients","volume":"118","author":"Cibeira","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.berh.2012.07.003_bib47","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2003-08-2788","article-title":"Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation","volume":"103","author":"Palladini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.berh.2012.07.003_bib48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa070484","article-title":"High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis","volume":"357","author":"Jaccard","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib49","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/qjmed\/hcr105","article-title":"Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects","volume":"104","author":"Dubrey","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.berh.2012.07.003_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00277-011-1244-x","article-title":"Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide","volume":"91","author":"Palladini","year":"2012","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.berh.2012.07.003_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2215\/CJN.02470607","article-title":"Presentation and outcome of patients with systemic amyloidosis undergoing dialysis","volume":"3","author":"Boll\u00e9e","year":"2008","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.berh.2012.07.003_bib52","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TP.0b013e3181f10edb","article-title":"Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure","author":"Dey","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.berh.2012.07.003_bib53","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfr067","article-title":"Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation","volume":"26","author":"Herrmann","year":"2011","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.berh.2012.07.003_bib54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/jnnp.60.6.655","article-title":"Myopathy in primary systemic amyloidosis","volume":"60","author":"Gertz","year":"1996","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.berh.2012.07.003_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00190993","article-title":"MRI evaluation of amyloid myopathy","volume":"21","author":"Metzler","year":"1992","journal-title":"Skeletal Radiology"},{"key":"10.1016\/j.berh.2012.07.003_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-198605000-00005","article-title":"Jaw claudication in primary systemic amyloidosis","volume":"65","author":"Gertz","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2012.07.003_bib57","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/art.1780360320","article-title":"Primary systemic amyloidosis masquerading as giant cell arteritis. Case report and review of the literature","volume":"36","author":"Rao","year":"1993","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.07.003_bib58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00005792-197507000-00001","article-title":"Amyloidosis: review of 236 cases","volume":"54","author":"Kyle","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2012.07.003_bib59","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Seminars in Hematology"},{"key":"10.1016\/j.berh.2012.07.003_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000478-199702000-00007","article-title":"Amyloidoma of bone plasma cell\/plasmacytoid neoplasm. Report of three cases and review of the literature","volume":"21","author":"Pambuccian","year":"1997","journal-title":"The American Journal of Surgical Pathology"},{"key":"10.1016\/j.berh.2012.07.003_bib61","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.rco.2008.03.029","article-title":"Amylose primitive et \u00e9tag\u00e9e du rachis dorsolombaire compliqu\u00e9e d'une parapl\u00e9ie","volume":"94","author":"Ajlani","year":"2008","journal-title":"Rev chir r\u00e9parat l'appareil locomoteur"},{"key":"10.1016\/j.berh.2012.07.003_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00007632-199801010-00027","article-title":"Case report and review of the literature: Cervical Amyloidoma of C2","volume":"23","author":"Porchet","year":"1998","journal-title":"Spine"},{"key":"10.1016\/j.berh.2012.07.003_bib63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1744-9987.2006.00383.x","article-title":"Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients","volume":"10","author":"Saito","year":"2006","journal-title":"Therapeutic Apheresis and Dialysis"},{"key":"10.1016\/j.berh.2012.07.003_bib64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1525-139X.2006.00134.x","article-title":"Dialysis-related amyloidosis: late finding or hidden epidemic?","volume":"19","author":"Dember","year":"2006","journal-title":"Seminars in Dialysis"},{"key":"10.1016\/j.berh.2012.07.003_bib65","first-page":"368","article-title":"Comparative evaluation of beta2-microglobulin removal by different hemodialysis membranes: a six year follow-up","volume":"63","author":"Mrowka","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.berh.2012.07.003_bib66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000086554","article-title":"Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients","volume":"23","author":"Furuya","year":"2005","journal-title":"Blood Purification"},{"key":"10.1016\/j.berh.2012.07.003_bib67","series-title":"Encycl Med Chir","article-title":"Complications ost\u00e9o-articulaires des h\u00e9modialys\u00e9s","author":"Gaucher","year":"1997"},{"key":"10.1016\/j.berh.2012.07.003_bib68","series-title":"Nouvelles manifestations articulaires chez l'h\u00e9modialys\u00e9. L'actualit\u00e9 rhumatologique","author":"Bardin","year":"1986"},{"key":"10.1016\/j.berh.2012.07.003_bib69","series-title":"Flammarion","first-page":"429","article-title":"Amylose \u00e0 la B\u00eata 2-microglobuline. In les amyloses","author":"Zingraff","year":"1995"},{"key":"10.1016\/j.berh.2012.07.003_bib70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780270402","article-title":"Destructive spondylarthropathy in hemodialyzed patients: a new syndrome","volume":"7","author":"Kuntz","year":"1984","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.07.003_bib71","first-page":"459","article-title":"Spondylarthropathie destructrice avec dep\u00f4ts amylo\u00efdes chez 3 patients en h\u00e9modialyse chronique","volume":"53","author":"Sebert","year":"1986","journal-title":"Revue du rhumatisme et des maladies ost\u00e9o-articulaires"},{"key":"10.1016\/j.berh.2012.07.003_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/13506120308995254","article-title":"A transthyretin mutation (Tyr78Phe) associated with peripheral neuropathy, carpal tunnel syndrome and skin amyloidosis","volume":"10","author":"Magy","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.berh.2012.07.003_bib73","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/01.wnl.0000267338.45673.f4","article-title":"Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)","volume":"69","author":"Plant\u00e9-Bordeneuve","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.berh.2012.07.003_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13506120410001673884","article-title":"End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors","volume":"11","author":"Lobato","year":"2004","journal-title":"Amyloid"},{"key":"10.1016\/j.berh.2012.07.003_bib75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/brain\/122.2.183","article-title":"Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis","volume":"122","author":"Brett","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.berh.2012.07.003_bib76","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0025-6196(12)60388-7","article-title":"Familial amyloidosis: a study of 52 north-american-born patients examined during a 30-year period","volume":"67","author":"Gertz","year":"1992","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.berh.2012.07.003_bib77","first-page":"1599","article-title":"Familial amyloid polyneuropathy: hypertrophy of ligaments supporting the spinal cord","volume":"25","author":"Kitajima","year":"2004","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.berh.2012.07.003_bib78","first-page":"1003","article-title":"Spinal claudication in systemic amyloidosis","volume":"16","author":"Harats","year":"1989","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.07.003_bib79","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.berh.2012.07.003_bib80","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/jcp.48.11.984","article-title":"The age related amyloids: a growing family of unique biochemical substances","volume":"48","author":"Cornwell","year":"1995","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.berh.2012.07.003_bib81","first-page":"1074","article-title":"Incidence of amyloidosis over 3 years: the AMYPRO study","volume":"26","author":"Magy-Bertrand","year":"2008","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.07.003_bib82","first-page":"232","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib83","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","article-title":"Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study","volume":"24","author":"Ueda","year":"2011","journal-title":"Modern Pathology"},{"key":"10.1016\/j.berh.2012.07.003_bib84","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/13506120209114102","article-title":"Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome","volume":"9","author":"Yi","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.berh.2012.07.003_bib85","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.berh.2012.07.003_bib86","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.humpath.2010.11.017","article-title":"Wild-type transthyretin-derived amyloidosis in various ligaments and tendons","volume":"42","author":"Sueyoshi","year":"2011","journal-title":"Human Pathology"},{"key":"10.1016\/j.berh.2012.07.003_bib87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13506129.2011.582197","article-title":"Spinal multifocal amyloidosis derived from wild-type transthyretin","volume":"18","author":"Sueyoshi","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.berh.2012.07.003_bib88","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF01605294","article-title":"Amyloid in intervertebral discs of surgery and autopsy material. A new class of amyloid?","volume":"416","author":"Wullbrand","year":"1990","journal-title":"Virchows Archiv A"},{"key":"10.1016\/j.berh.2012.07.003_bib89","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1002\/art.22201","article-title":"Amyloid contained in the knee joint meniscus is formed from Apolipoprotein A-I","volume":"11","author":"Solomon","year":"2006","journal-title":"Arthritis & Rheumatism"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694212000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694212000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T13:31:56Z","timestamp":1594733516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694212000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1521694212000666"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2012.07.003","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}